Методические рекомендации Республиканский научно-практический центр неврологии и нейрохирургии Республики Беларусь (стр. 13 из 14)
9. Лихачев С.А., Строцкий А.В., Забродец Г.В. Способ восстановления мочеиспускания при спинальной патологии с надсакральным уровнем патологии // Официальный бюллетень: Изобретения, полезные модели, промышленные образцы – 2009. – 4–69. – С. 72.
10. Лихачев С.А., Строцкий А.В., Забродец Г.В., Рагузин А.А. Первый опыт лечения нейрогенной гиперактивности детрузора препаратом ботулотоксина А Диспорт в Беларуси // Медицинские новости. – 2010. – № 1. – С. 35–38.
11. Лопаткин Н.А. Спинальный мочевой пузырь // Руководство по урологии: В 3-х т. Т.2 / Под ред. Н.А. Лопаткина. – М.: Медицина, 1998. – с. 251 – 258.
12. Лопаткин Н.А., Вишневский Е.П. Нейрогенная дисфункция мочевого пузыря // Руководство по урологии: В 3-х т. Т.2 / Под ред. Н.А. Лопаткина. – М.: Медицина, 1998. – С. 232–250.
13. Мазо Е.Б., Кривобородов Г.Г., Школьников М.Е. Ботулинический токсин у больных с нейрогенной дисфункцией нижних мочевых путей // Урология. – 2004. – № 4. – С. 44–48.
14. Савченко Н.Е., Мохорт В.А. Нейрогенные расстройства мочеиспускания. — Минск: Беларусь, 1970. — 244 с.
15. Хейнманн Ф.Б. Иннервация мочевыводящих органов. — Минск: Наука и техника, 1973. — 224 с.
16. Яриков Д.Е. Международные стандарты в оценке неврологических нарушений при травме позвоночника и спинного мозга / Д.Е. Яриков, И.Н. Шевелев, А. В. Басков // Вопросы нейрохирургии. – 1999. – № 1. – С. 36–38.
17. Abrams P. Urodynamics / London: Springer, 2006. – 339 p.
18. Abrams P., Cardozo L., Fall M. at al. The standartisation of terminology in lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society // Neurourol. Urodyn. – 2002. – Vol. 21. – P.167–178.
19. Amend, B. Effective treatment of Neurogeic Detrusor Dysfunction by combined high-dosed antimuscarinics without increased side-effects / B. Amend [at al.] // European Urology. – 2008. – Vol. 53. – P. – 1021 –1028.
20. Apostolidis A., Dasgupta P., Fowler C.J. Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity // Eur Urol. – 2006. – Vol. 49. – P. 644–650.
21. Apostolidis A., Haferkamp A., Aoki A.R. Understanding the Role of Botulinum Toxin A in the Treatment of the Overactive Bladder More than Just Muscle Relaxation // Eur Urol. – 2006. – Suppl. 5. – P. 670–678.
22. Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers / consortium for spinal cord medicine [Electronic resource]. – Paralyzed Veterans of America, 2006. – Mode of access: http://www.pva.org/site/DocServer/Bladder. WEB.pdf?docID=1101.
23. Burns A.S., Rivas D.A., Ditunno J.F. The management of neurogenic bladder and sexual dysfunction after spinal cord injury // Spine. – 2001. – Vol. 26 (Suppl). – P. 129–136.
24. Chapple Ch., Khullar V., Gabriel Z. at al. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis // Eur. Urol. – 2008. – Vol. 54, № 3. – P. 543–562.
25. Curt A., Rodic B., Schurch B. et al. Recovery of bladder function in patients with acute spinal cord injury: significance of ASIA scores and somatosensory evoked potentials // Spinal Cord. – 1997. – Vol. 35, № 6. – Р. 368–373.
26. Dykstra D.D. Use of Botulinum Toxin in Urologyc Disorder // Scientific and therapeutic aspects of Botulinum toxin / edited by M. F. Brin, J. Jancovic, M. Hallett-Lippincott. – Philadelphia: Williams and Wilkins, 2002. – P. 351–356.
27. Dykstra D.D., Sidi A.A., Scott A.B. et al. Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients // J Urol. – 1988. – Vol. 139. – P. 919–922.
28. Fowler C. Intravesical treatment of overactive bladder // Urology. – 2000. – Vol. 55, № 5A. – P. 60–64.
29. Frawley H. Pelvic floor muscle strength testing // Australian Journal of Physiotherapy. – 2006. – Vol. 52. – P.307.
30. Game X., Castel-Lacanal E., Bentaleb Y., at al. Botulinum toxin A detrusor injections in patients with Neurogeic Detrusor Overactivity significantly decrease the incidence of symptomatic urinary tract infections // Eur Urol. – 2008. –Vol. 53. – P. 613 – 619.
31. Giannantoni A., Di Stasi S.M., Stephen R.L. et al. // J. Urol. – 2004. – Vol. 172. – P. 240–243.
32. Giannantoni A., Scivoletto G., Di Stasi S.M. et al. Clean intermittent catheterization and prevention of renal disease in spinal cord injury patients / Spinal Cord. – 1998. –Vol. 36. – P. 29–32.
33. Griffiths D., Hofner K. et al. Standartization of Terminology of Lower Urinary Tract Function: Pressure-Flow Studies of Voiding, Urethral Resistance and Urethral Obstruction // Neurourol. Urodyn. – 1997. – Vol. 16. – P. 1–18.
34. Groah S.L., Weitzenkamp D., Sett P. at al. The relationship between neurological level of injury and symptomatic cardiovascular disease risk in the aging spinal injured // Spinal Cord. – 2001. – Vol. 39, № 6. – P.310–317.
35. Groat W.C., Booth A.M. Autonomic systems to the urinary bladder and sexual organs // Peripheral neuropathy. – Vol. 1. / edited by P.J. Dyck [at al.]. – W.B. Saunders Company, 1984. – Vol. 1. – P. 285–299.
36. Grosse J., Kramer G., Stohrer M. Success of Repeat Detrusor Injections with Severe Neurogeic Detrusor Overactivity and Incontinence // Eur Urol. – 2005. – Vol. 47. – P. 653–659.
37. Harper M., Fowler C.J., Dasgupta P. Botulinum toxin and its applications in the lower urinary tract // BJU Int. – 2004. – Vol. 93. – P. 702–706.
38. Kaplan S.A., Chancellor M.B., Blaivas J.G. Bladder and sphincter behavior in patients with spinal cord lesion // J. Urol. – 1991. – Vol. 146, № – P. 113–117.
39. Karsenty G., Boy S., Reits A. et al. Botulinum toxin-A (BTA) in the treatment of neurogenic detrusor overactivity incontinence (NDOI)—a prospective randomized study to compare 30 vs. 10 injection sites. International Continence Society Annual Meeting, Montreal, Canada, Aug. 31-Sep. 2, 2005 (abstract no. 93).
40. Kawano P.R., Amaro J.L., Silva F.S. at al. Conventional Urodynamics versus Simplified Cystometry for Characterization of Female Urinary Incontinence // RBGO. – 2004. – Vol. 26, № 4. – P. 311–316.
41. Kessler T. M., Madersbacher H., Kiss G. Prolonged sacral neuromodulation testing using permanent leads: a more reliable patient selection method? // Eur Urol. – 2005. – Vol. 47. – P. 660–665.
42. Kuo H.C. Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics // Urology. – 2005. – Vol. 66. – P. 94–98.
43. Madersbacher H. The various types of neurogenic bladder dysfunction: an update of current therapeutic concepts // Paraplegia. – 1990. – Vol. 28. – P. 217–229.
44. Maria G., Cadeddu F., Brisinda D. et al. Management of bladder, prostatic and pelvic floor disorders with botulinum neurotoxin // Curr Med Chem. – 2005. – Vol. 12. – P. 247–265.
45. Martin J.L., Williams K.S., Abrams K.R. at al. Systematic review and evaluation of methods of assessing urinary incontinence // Health Technol. Assess. – 2006. – Vol. 10, № 6. – P. 1–132.
46. Maynard F.M., Bracken M.B., Creasey G et al. International Standards for Neurological and Functional Classification of Spinal Cord Injury // Spinal Cord. – 1997. – Vol. 35, № 5. – Р. 266– 274
47. Ockrim J., Laniado M.E., Khoubehi B., Renzetti R. at al. Variability of detrusor overactivity on repeated filling cystometry in men with urge symptoms: comparison with spinal cord injury patients // BJU Int. – 2005. – Vol. 95, № 4. – P. 87–90.
48. Patel A., Patterson J., Chapple Ch. Botulinum Toxin Injection for Neurogenic and Idiopatic Detrusor Overactivity: A Critical Analysis of Results // Eur Urol. – Vol. 50. – 2006. – P. 684–710.
49. Penders J., Huylenbroeck A.A.Y., Everaert K. at al. Urinary infections in patients with spinal cord injury // Spinal Cord. – 2003. – Vol. 41, № 10. – P. 549–552.
50. Perkash I., Linsenmeyer T.A., Bodner D.R. at al. Detrusor-sphincter dyssynergia and vesico urethral reflux: management / I. Perkash [.] // Spinal Cord. – 1998. – Vol. 36, № 1. – P. 2–5.
51. Petit H., Wiart L., Gaujard E. at al. Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease // Spinal Cord. – 1998. – Vol. 36. – Р. 91–94.
52. Reitz A., Denys P., Fermanian Ch. at al. Do repeat intradetrusor Botulinum toxin type A injections yield valuable results? Clinical and urodynamics results after five injections in patients with Neurogeic Detrusor Overactivity // Eur Urol. – 2007. – Vol. 52. – P. 1729–1735.
53. Sacomani C.A.., Trigo-Rocha F.E., Gomes C.M. at al. Effect of the trauma mechanism on the bladder-sphincteric behavior after spinal cord injury // Spinal Cord. – 2003. – Vol. 41, № 1. – P. 12–15.
54. Schäfer W., Abrams P., Liao L. at al. Good Urodynamic Practices: Uroflowmetry, Filling Cystometry and Pressure-Flow Studies // Neurourol. Urodyn. – 2002. – Vol. 21. – P. 261–274.
55. Schurch B, Schmid D., Stohrer M. Treatment of neurogenic incontinence with botulinum toxin A // N Engl J Med. – 2000. – Vol. 342. – P. 665.
56. Schurch B., De Seze M., Denys P. et al. Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study // J Urol. – 2005. – Vol. 174. – P. 196–200.
57. Schurch B., Denys P., Kozma Ch.M. at al Botulinum Toxin A improves the quality of life of patients with neurogenic urinary incontinence // Eur Urol. – 2007. – Vol. 52. – P. 850 – 859.
58. Schurch B., Schmid D.M., Kaegi K. Value of sensory examination in predicting bladder function in patients with T12-L1 fractures and spinal cord injury // Arch. Phys. Med. Rehabil. – 2003. – Vol. 84, № 1. – P. 83–89.
59. Schurch B., Schmid D.M., Karsenty G. at al. Can neurologic examination predict type of detrusor sphincter-dyssynergia in patients with spinal cord injury? // Urology. – 2005. – Vol. 65, № 2. – P. 243–246.
60. Schurch B., Stohrer M., Kramer G. et al. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results // J Urol. – 2000. – Vol. 164. – P. 692–697.
61. Silva C., Silva J., Ribeiro M-J. at al. Urodynamic effect of intravesical resiniferatoxin in patients with Neurogeic Detrusor Overactivity of spinal origin: results of a double-blind randomized placebo-controlled triale // Eur. Urol. – 2005. – Vol. 48. – P. 650–655.
62. Stohrer M., Castro-Diaz D., Chartier-Kastler E. et al. Guidelines on neurogenic lower urinary tract dysfunction / European Association of Urology, 2003.
63. Stöhrer M., Goepel M., Kondo A. at al. The standardization of terminology in neurogenic lower urinary tract dysfunction with suggestions for diagnostic procedures // Neurourol. Urodyn. – 1999. – Vol. 18. – P. 139–158.
64. Sutherst J.R., Brown M.C. Comparison of single and multichannel cystometry in diagnosing bladder instability / BMJ. – 1984. – Vol. 288. – P. 1720–1722.
65. Suzuki T., Ushiyama T. Vesicoureteral reflux in the early stage of spinal cord injury: a retrospective study // Spinal Cord. – 2001. – Vol. 39. – P. 23–25.
66. Swash M. The conus medullaris and sphincter control // Diseases of the Spinal Cord; edited by E. Gritchley, A. Eisen. – Springer-Verlag London Limited, 1992.
67. Textbook of female urology and urogynecology / edited by L. Cardozo [at al.]. – UK: Informa Healthcare, 2006. – 1384 p.
68. Weld K.J., Dmochowski R.R. Effect of bladder management on urological complications in spinal cord injured patients / J Urol. – 2000. – Vol. 163. – P. 768–772.
69. Weld K.J., Dmochowski R.R. Association of level of injury and bladder behavior in patients with post-traumatic spinal cord injury // Urology. – 2000. – Vol. 55, № 4. – P. 490–494.
70. Weld K.J., Graney M.J., Dmochowski R.R. Clinical significance of detrusor sphincter dyssynergia type in patients with post-traumatic spinal cord injury // Urology. – 2000. – Vol. 56, № 4. – P. 565–568.
71. Wyndaele J.J. Complications of intermittent catheterization: their prevention and treatment // Spinal Cord. – 2002. – Vol. 40, № 10. – P. 536–541.
72. Wyndaele J.J. Correlation between clinical neurological data and urodynamic function in spinal cord injured patients // Spinal Cord. – 1997. – Vol. 35, № 4. – P. 213–216.
73. Wyndaele J.J., THi H.Vo., Pham B.C. at al. The use of one-channel water cystometry in patients with a spinal cord lesion: practicalities, clinical value and limitations for the diagnosis of neurogenic bladder dysfunction // Spinal Cord. – 2009. – Vol. 47, № 7. – P. 526–530.
Приложение
Рисунок 1. Иннервация нижних мочевых путей (L. Cardozo, 2006).
Рисунок 2. Классификация нейрогенной дисфункции НМП (по Madersbacher)
Рисунок 3. Дерматомы и рефлексы (коленный L2-4, ахиллов L5-S2, анальный S4-5, кремастерный, бульбокавернозный L5-S5) [62] .
